Conference Venue:
Renaissance Brussels Hotel

Description:
The risks and benefits of research remain a central consideration in drug development, research design, review and regulation. It’s a central concern within the new proposed EU Clinical Trial Regulations.

Yet there is little evidence on which to build our judgments and found a balanced approach. Without evidence, risks are exaggerated and the benefits played down. Medical and drug development is undermined, researchers are cautious, monitors without clear and appropriate objectives and as importantly potential research participants ill- or un-informed. There is an urgent need for re-evaluation and a coordinated approach to resolve these problems.

Website

Event Secretariat:
European Forum for Good Clinical Practice (EFGCP)
Rue de l'Industrie 4
Brussels 1000
Belgium
 
Phone +3227328783
conferences[at]efgcp.eu